System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Prof Didier Carrié is an expert in Cardiology at Centre Hospitalier Universitaire de Toulouse (France). As of October 2026, ScienceLeadR ranks Didier Carrié in the top 1% of experts worldwide for Coronary Disease and Myocardial Ischemia. Didier Carrié has authored 623 publications, the most recent in 2026, and is an investigator in 42 clinical trials, 1 of them ongoing. SLR score: 1,799 (community average: 125). How the SLR is computed.

LeadR Profile

Prof Didier Carrié Centre Hospitalier Universitaire de Toulouse France
1 799 ScienceLeadR Reputation 1799

Unlock

Register Login
Network Map

Cardiology

Subspecialties: Public Health - Thoracic And Cardiovascular Surgery - Surgery

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1988 - 2026
Source: PubMed

Centre Hospitalier Universitaire de Toulouse

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 623

Citations

Citations: 36 479 1st author: 35 Last author: 74 Unique author: 26

Main journals

J Am Coll Cardiol 53
Archives of Cardiovascular Diseases Supplements 52
Arch Mal Coeur Vaiss 33
EuroIntervention 33
Eur Heart J 30

Best Journals

N Engl J Med 14
Eur Heart J 2

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Comparison of primary prevention strategy guided by SCORE2 versus coronary artery calcium scoring in a non-diabetic population.
PMID 41506959 — internal medicine, arteries, calcium, primary prevention		Eur J Intern Med20260
Ticagrelor promotes arterial healing and shows superiority to clopidogrel in preventing neoatherosclerosis.
PMID 41367713 — ticagrelor, clopidogrel		Blood Vessel Thromb Hemost20250
Impact of collaborative pharmaceutical care on older inpatients' medication safety: multicentre stepped-wedge cluster randomised trial (MEDREV Study).
PMID 40646458 — safety, pharmaceutical preparations, medication errors, geriatrics		BMC Geriatr20250
Predictors of Outcomes of Reintervention After Transcatheter Aortic Valve Replacement: FRANCE 2 and FRANCE TAVI Registries.
PMID 40044295 — registries, mortality, aortic valve stenosis, incidence, life expectancy, cardiology, aortic valve, transcatheter aortic valve replacement		J Am Coll Cardiol20252
Coronary Events After Transcatheter Aortic Valve Replacement: Insights From the France TAVI Registry.
PMID 39880575 — registries, constriction, pathologic, hospitalization, coronary artery disease, incidence, percutaneous coronary intervention, arteries, aortic valve, transcatheter aortic valve replacement		JACC Cardiovasc Interv20251

Clinical Studies 42

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 5

By phase:

N/A 19
Phase 3 13
Phase 4 7
Phase 2 3

By status:

Completed 33
Unknown 7
Recruiting 1
Terminated 1

By type:

Interventional 38
Observational 4

By Monocentric/Multicentric:

monocentric 16
multicentric2to4 4
multicentric5to9 3
multicentricup10 19

Main Topics

Cohort/Consortium Investigators 1

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Rituximab in patients with ST elevation myocardial infarction A phase 2 placebo controlled randomized clinical trial
2022-501893-21-00 — myocardial infarction, st elevation myocardial infarction, rituximab		Phase 2Recruiting2022

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS